Editorial: aminosalicylates in Crohn's disease-prevalence, risks, costs and time to re-assess?

Mansfield, J

Editorial: aminosalicylates in Crohn's disease-prevalence, risks, costs and time to re-assess? [electronic resource] - Alimentary pharmacology & therapeutics 08 2018 - 487-488 p. digital

Publication Type: Editorial; Comment

1365-2036

10.1111/apt.14859 doi


Crohn Disease
Humans
Mesalamine
Prevalence
Remission Induction
Risk Factors